|

Sarantis: Q4 Below Guidance; Sales/EBITDA re-base Towards Higher Margin Mix; 2028/E120m EBITDA Target Reiterated

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In
   

Similar Posts